Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danilo Fliser

Showing results (131-140 of 293) with videos related to

Pageof 30
Sort By:
Journal of Clinical Immunology|July 17, 2012
T-cell numbers and antigen-specific T-cell function follow different circadian rhythmsSarah Kirsch, Stephan Thijssen, Susana Alarcon Salvador, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 13, 2016
NT-proBNP and Echocardiographic Parameters for Prediction of Cardiovascular Outcomes in Patients with CKD Stages G2-G4Kathrin Untersteller, Nicolas Girerd, Kevin Duarte, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 7, 2022
What should European nephrology do with the new CKD-EPI equation?Ron T Gansevoort, Hans-Joachim Anders, Mario Cozzolino, et al.
Critical Care Medicine|December 24, 2005
Pharmacokinetics and total elimination of meropenem and vancomycin in intensive care unit patients undergoing extended daily dialysisJan T Kielstein, David Czock, Timo Schöpke, et al.
Journal of the American Society of Nephrology : JASN|August 24, 2014
Competitive interaction between fibroblast growth factor 23 and asymmetric dimethylarginine in patients with CKDGiovanni Tripepi, Barbara Kollerits, Daniela Leonardis, et al.
American Journal of Nephrology|February 12, 2008
Toll-like receptor 2 and renal allograft functionKirsten de Groot, Katharina Kuklik, Verena Bröcker, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 7, 2018
Association of Nonoxidized Parathyroid Hormone with Cardiovascular and Kidney Disease Outcomes in Chronic Kidney DiseaseSarah Seiler-Mussler, Anne S Limbach, Insa E Emrich, et al.
Critical Care (London, England)|November 26, 2008
Excess circulating angiopoietin-2 is a strong predictor of mortality in critically ill medical patientsPhilipp Kümpers, Alexander Lukasz, Sascha David, et al.
Intensive Care Medicine|December 4, 2009
Angiopoietin-2 in patients requiring renal replacement therapy in the ICU: relation to acute kidney injury, multiple organ dysfunction syndrome and outcomePhilipp Kümpers, Carsten Hafer, Sascha David, et al.
Journal of Hepatology|December 4, 2003
Prometheus--a new extracorporeal system for the treatment of liver failureKinan Rifai, Thomas Ernst, Ulrich Kretschmer, et al.
Pageof 30

Showing results (131-140 of 293) with videos related to

Sort By:
Pageof 30
Journal of Clinical Immunology|July 17, 2012
T-cell numbers and antigen-specific T-cell function follow different circadian rhythmsSarah Kirsch, Stephan Thijssen, Susana Alarcon Salvador, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 13, 2016
NT-proBNP and Echocardiographic Parameters for Prediction of Cardiovascular Outcomes in Patients with CKD Stages G2-G4Kathrin Untersteller, Nicolas Girerd, Kevin Duarte, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 7, 2022
What should European nephrology do with the new CKD-EPI equation?Ron T Gansevoort, Hans-Joachim Anders, Mario Cozzolino, et al.
Critical Care Medicine|December 24, 2005
Pharmacokinetics and total elimination of meropenem and vancomycin in intensive care unit patients undergoing extended daily dialysisJan T Kielstein, David Czock, Timo Schöpke, et al.
Journal of the American Society of Nephrology : JASN|August 24, 2014
Competitive interaction between fibroblast growth factor 23 and asymmetric dimethylarginine in patients with CKDGiovanni Tripepi, Barbara Kollerits, Daniela Leonardis, et al.
American Journal of Nephrology|February 12, 2008
Toll-like receptor 2 and renal allograft functionKirsten de Groot, Katharina Kuklik, Verena Bröcker, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 7, 2018
Association of Nonoxidized Parathyroid Hormone with Cardiovascular and Kidney Disease Outcomes in Chronic Kidney DiseaseSarah Seiler-Mussler, Anne S Limbach, Insa E Emrich, et al.
Critical Care (London, England)|November 26, 2008
Excess circulating angiopoietin-2 is a strong predictor of mortality in critically ill medical patientsPhilipp Kümpers, Alexander Lukasz, Sascha David, et al.
Intensive Care Medicine|December 4, 2009
Angiopoietin-2 in patients requiring renal replacement therapy in the ICU: relation to acute kidney injury, multiple organ dysfunction syndrome and outcomePhilipp Kümpers, Carsten Hafer, Sascha David, et al.
Journal of Hepatology|December 4, 2003
Prometheus--a new extracorporeal system for the treatment of liver failureKinan Rifai, Thomas Ernst, Ulrich Kretschmer, et al.
Pageof 30